⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
PFE
CSL
SNY
BMRN
ALNY
SANG
BE
REGN
NTLA
JNJ
ABBV
BMY
TEO
VRTX
CRSP
AI in GxP Environments | 9-Hour Online Training Course - Provides Frameworks for Decision-Grade AI Implementation Vital for QA, Regulatory, and Governance Professionals
globenewswire.com
JNJ
MRK
SNY
GSK
Breast Cancer Canada’s annual Walk-a-Thon to Mother’s Day returns to advance breast cancer research.
businesswire.com
AMGN
MRK
PFE
BMY
GILD
ABBV
AZN
JNJ
LULU
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
prnewswire.com
JNJ
Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease
prnewswire.com
JNJ
Longwood Healthcare Leaders to Host MIT CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders at MIT Koch Institute
accessnewswire.com
BIIB
ALNY
MRNA
REGN
JNJ
BEAM
IONS
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
businesswire.com
JNJ
Join the Lupus Research Alliance's Walk with Us to Cure Lupus on May 9 at New Jersey's Meadowlands Racetrack
prnewswire.com
JNJ
Par Health Names Norv McAndrew as EVP, Chief Legal Officer and Corporate Secretary
prnewswire.com
TEVA
JNJ
PFE
PRPH
CAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis
prnewswire.com
JNJ